The effect of interferon alpha plus Ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience

Journal of Gastrointestinal and Liver Diseases

Volumn 15, Issue 1, 2006, Pages 31-35

  Pojoga, Cristina ^a   Dumitraşcu, Dan L ^a   Pascu, Oliviu ^a   Grigorescu, Mircea ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Chronic C hepatitis; Health related quality of life; Therapy

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEPATITIS C; HUMAN; MALE; PIACENZIAN; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 33744936281     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Davis GL, Balart LA, Schiff ER, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 1994;16:334-43.
2. Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 2001;96:579-83.
3. Neary MP, Cort S, Bayliss MS, Ware JE Jr. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients. Semin Liver Dis 1999;19:77-85.
4. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29:264-70.
5. Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment. Dig Liver Dis 2000;32:398-405.
6. Hunt CM, Dominitz JA, Bute BP, Waters B, Blasi U, Williams DM. Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci 1997;42:2482-6.
7. McHutchison JG, Ware JE Jr, Bayliss MS, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. Hepatitis Interventional Therapy Group. J Hepatol 2001; 34:140-147.
8. Foster GR. Hepatitis C virus infection: quality of life and side effects of treatment. J Hepatol 1999; 31 Suppl 1: 250-254.
9. Iorio R, Pensati P, Botta S, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997;16:984-90.
10. Bayliss MS. Methods in outcomes research in hepatology: definitions and domains of quality of life. Hepatology 1999; 29:3S-6S.
11. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27:209-12.
12. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE Jr. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998; 7:39-55.
13. Szanto P, Grigorescu M, Pascu O. et al. Hepatitis B, C and D virus infection in chronic liver disease in Transylvania, Romania. Clinical correlations. Rom J Gastroenterol 1995;4:199-204.
14. Voinea F, Dumitru E, Adam T, Vinteanu I, Nicolae A. The prevalence of infection with hepatitis B and C viruses in Constanta. Rom J Gastroenterol 1998;8:185-188.
15. Sporea I, Jenariu S, Sabau M, et al. Prevalence of antiHCV antibodies in blood donors in Romania, Rom J Gastroenterol 2000;9:167-170.
16. Pojoga C, Dumitrascu DL, Pascu O, Grigorescu M, Radu C, Damian D. Impaired health-related quality of life in Romanian patients with chronic viral hepatitis before antiviral therapy. Eur J Gastroenterol Hepatol 2004; 16:27-31.
17. Ware JE Jr., Sherbourne CD. The Medical Outcomes Study (MOS) 36-item short-form health survey (SF-36) 1. Conceptual framework and item selection. Med Care 1992;30:473-483.
18. McHorney CA, Ware JE Jr., Lu JF, Sherbourne CD. The Medical Outcomes Study (MOS) 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 1994;32:40-66.
19. McHorney CA., Ware JE Jr., Raczek AE. The Medical Outcomes Study (MOS) 36-item Short-Form Heath Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31:247-263.
20. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305:160-164.
21. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status intruments. Med Care 1992;30:917-925.
22. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-1444.
23. Phillips RC, Lansky DJ. Outcomes management in heart valve replacement surgery: early experience. J Heart Valve Dis 1992;1:42-150.
24. Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health status measures in outpatient dialysis: early experiences in developing an outcomes assessment program. Med Care 1992;30:MS136-MS149.
25. Ware JE Jr., Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of the disease and treatment response. The Interventional Therapy Group, Hepatology 1999;30: 550-555.
26. Bonkowsky et al. Quality of life in chronic hepatitis C. Hepatology 1999; 29:264-270.
27. Carithers RL Jr., Sugano D, Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci 1996;417: 75S-80S.
28. Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J., Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002; 35: 704-708.
29. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
30. David C. Quality of life. "Psycho-oncology" ed. Holland Jimmie, 1988, Oxford University Press.
31. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996